Green Orange Blue Creative Healthcare Facility Presentation

[Audio] IDOSE TR Role play between medical rep and.

[Audio] DOCTOR MEDICAL REP GOOD MORNING, DR. SMITH. I HOPE YOU'RE DOING WELL TODAY. GOOD MORNING. YES, I'M DOING FINE, THANK YOU. HOW CAN I HELP YOU?.

[Audio] Doctor Medical rep I've heard a bit about iDose TR. What makes it stand out from other treatments for glaucoma? I'm here to discuss a new treatment option for glaucoma patients that I believe could greatly benefit your practice. It's called iDose TR, manufactured by Glaukos Corporation, and it's been making waves in the ophthalmology community..

[Audio] Medical rep Doctor iDose TR is a sustained-release implant that delivers a consistent dose of medication directly into the eye over an extended period of time. It offers a unique advantage by providing a continuous therapeutic effect, reducing the need for frequent administration of eye drops. Plus, it comes in different doses, allowing for personalized treatment plans tailored to each patient's specific needs. What makes it stand out from other treatments for glaucoma?.

[Audio] Medical rep Doctor There have been several clinical trials evaluating the effectiveness of iDose TR, all conducted by Glaukos Corporation. One study published in the Journal of Glaucoma compared iDose TR to topical eye drops and found that patients receiving iDose TR had significantly lower IOP levels and required fewer additional medications. to control their glaucoma. Additionally, another study published in the American Journal of Ophthalmology demonstrated that iDose TR had a favorable safety profile with minimal adverse events reported. That sounds promising. What evidence supports its efficacy and safety?.

[Audio] Doctor Impressive. And what about the cost? MEDICAL rep While the initial cost of iDose TR may be higher than traditional eye drop therapies, it's essential to consider the long-term benefits and potential cost savings. With iDose TR's sustained-release mechanism, patients may require fewer additional medications and fewer office visits for medication adjustments over time. Additionally, many insurance plans cover iDose TR, so it's worth checking with individual insurance providers to understand coverage options..

[Audio] Medical rep Doctor What about potential side effects? While iDose TR has demonstrated a favorable safety profile in clinical trials, it's essential to be aware of potential side effects. Common side effects may include mild discomfort or irritation at the implantation site, transient changes in vision, and rare instances of infection or inflammation. However, serious adverse events are rare with iDose TR. Patients should be informed about these potential side effects and instructed to contact their healthcare provider if they experience any concerning symptoms..

[Audio] Thank you for providing this comprehensive overview. I'm definitely interested in incorporating iDose TR into my treatment options for glaucoma patients. Can you tell me more about the different doses available and how they fit into the treatment plan? Certainly, iDose TR comes in different doses, allowing for personalized treatment plans based on each patient's specific needs and severity of glaucoma. The implant delivers a consistent dose of medication over a predetermined period, typically ranging from several months to a year. This allows for a convenient and effective treatment option that can be tailored to each patient's individual response and disease progression..

[Audio] Doctor Medical rep Absolutely, I'll provide you with all the necessary resources and support. Thank you for considering iDose TR as a valuable addition to your practice. That makes sense. Thank you for clarifying. Please provide me with more information, including dosing guidelines and educational materials, so I can further explore incorporating iDose TR into my practice..